GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
-7.41%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.81B
AUM Growth
-$443M
(-14%)
Cap. Flow
-$84.3M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
26.83%
Holding
197
New
22
Increased
81
Reduced
80
Closed
14
Top Buys
| 1 |
CCC Intelligent Solutions
CCCS
|
$21.3M |
| 2 |
Genius Sports
GENI
|
$20.7M |
| 3 |
ODDITY Tech
ODD
|
$17.9M |
| 4 |
Gentherm
THRM
|
$13.9M |
| 5 |
Life Time Group Holdings
LTH
|
$12.4M |
Top Sells
| 1 |
SPS Commerce
SPSC
|
$28M |
| 2 |
Azenta
AZTA
|
$27.8M |
| 3 |
Twilio
TWLO
|
$25.1M |
| 4 |
Enphase Energy
ENPH
|
$23.3M |
| 5 |
Paycom
PAYC
|
$20.8M |
Sector Composition
| 1 | Technology | 39.71% |
| 2 | Healthcare | 20.5% |
| 3 | Industrials | 16.31% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Communication Services | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
SolarEdge
SEDG
$2.03B
| $4.9M | 0.17% |
37,847
+936
| +3% | +$121K |
|
127
Rapid7
RPD
$1.28B
| $4.84M | 0.17% |
105,642
-138,281
| -57% | -$6.33M |
|
128
MoonLake Immunotherapeutics
MLTX
$3.79B
| $4.82M | 0.17% |
84,562
+12,628
| +18% | +$720K |
|
129
Zymeworks
ZYME
$1.07B
| $4.57M | 0.16% |
721,181
+79,039
| +12% | +$501K |
|
130
Bright Horizons
BFAM
$6.62B
| $4.5M | 0.16% |
55,257
+4,631
| +9% | +$377K |
|
131
Radware
RDWR
$1.06B
| $4.49M | 0.16% |
265,322
-201,120
| -43% | -$3.4M |
|
132
JFrog
FROG
$5.65B
| $4.36M | 0.16% |
172,067
+67,153
| +64% | +$1.7M |
|
133
FIVE9
FIVN
$2.03B
| $4.26M | 0.15% |
66,175
+29,005
| +78% | +$1.87M |
|
134
Okta
OKTA
$15.8B
| $4.23M | 0.15% |
51,889
+2,062
| +4% | +$168K |
|
|
SMAR
135
DELISTED
Smartsheet Inc.
SMAR
| $4.18M | 0.15% |
103,241
+44,924
| +77% | +$1.82M |
|
136
Sprinklr
CXM
$2.03B
| $4.08M | 0.15% |
+294,567
| New | +$4.08M |
|
|
RVNC
137
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.08M | 0.15% |
355,360
+66,433
| +23% | +$762K |
|
138
Grocery Outlet
GO
$1.78B
| $4.03M | 0.14% |
139,644
-58,314
| -29% | -$1.68M |
|
139
ThredUp
TDUP
$1.44B
| $3.98M | 0.14% |
993,008
-2,003,433
| -67% | -$8.03M |
|
140
Stoneridge
SRI
$234M
| $3.89M | 0.14% |
194,050
-163,130
| -46% | -$3.27M |
|
141
CEVA Inc
CEVA
$534M
| $3.8M | 0.14% |
195,720
-146,911
| -43% | -$2.85M |
|
142
Arcus Biosciences
RCUS
$1.23B
| $3.51M | 0.13% |
195,599
-119,237
| -38% | -$2.14M |
|
143
Stoke Therapeutics
STOK
$1.08B
| $3.35M | 0.12% |
851,201
+318,321
| +60% | +$1.25M |
|
144
Rogers Corp
ROG
$1.44B
| $3.19M | 0.11% |
+24,273
| New | +$3.19M |
|
|
HCP
145
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $3.04M | 0.11% |
133,077
+70,403
| +112% | +$1.61M |
|
|
146
Twilio
TWLO
$16.3B
| $2.95M | 0.11% |
50,412
-429,069
| -89% | -$25.1M |
|
147
Boot Barn
BOOT
$5.83B
| $2.95M | 0.1% |
+36,273
| New | +$2.95M |
|
148
Cytosorbents Corp
CTSO
$61.2M
| $2.92M | 0.1% |
1,552,393
-64,194
| -4% | -$121K |
|
149
Apellis Pharmaceuticals
APLS
$3.62B
| $2.9M | 0.1% |
76,120
-37,655
| -33% | -$1.43M |
|
150
BridgeBio Pharma
BBIO
$9.91B
| $2.87M | 0.1% |
+108,821
| New | +$2.87M |
|